Brian Weinstein
Stock Analyst at William Blair
(0.29)
# 3,262
Out of 4,496 analysts
8
Total ratings
33.33%
Success rate
-19.18%
Average return
Main Sectors:
Top Industries:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Downgrades: Market Perform | n/a | $16.70 | - | 2 | Jul 15, 2022 | |
| GKOS Glaukos | Upgrades: Outperform | n/a | $120.73 | - | 2 | Feb 3, 2022 | |
| SERA Sera Prognostics | Initiates: Outperform | n/a | $7.80 | - | 1 | Aug 9, 2021 | |
| BDSX Biodesix | Initiates: Outperform | n/a | $1.77 | - | 1 | Nov 23, 2020 | |
| AWH Aspira Women's Health | Initiates: Outperform | n/a | $1.48 | - | 1 | Oct 30, 2020 | |
| QDEL QuidelOrtho | Upgrades: Outperform | n/a | $34.69 | - | 1 | Jul 18, 2017 |
10x Genomics
Jul 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $16.70
Upside: -
Glaukos
Feb 3, 2022
Upgrades: Outperform
Price Target: n/a
Current: $120.73
Upside: -
Sera Prognostics
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.80
Upside: -
Biodesix
Nov 23, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.77
Upside: -
Aspira Women's Health
Oct 30, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.48
Upside: -
QuidelOrtho
Jul 18, 2017
Upgrades: Outperform
Price Target: n/a
Current: $34.69
Upside: -